{"id":22554,"date":"2026-02-24T02:16:08","date_gmt":"2026-02-24T02:16:08","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/22554\/"},"modified":"2026-02-24T02:16:08","modified_gmt":"2026-02-24T02:16:08","slug":"hims-hers-health-novo-nordisk-paypal-uber-and-bwx-technologies-why-these-5-stocks-are-on-investors-radars-today-hims-hers-health-nysehims","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/22554\/","title":{"rendered":"Hims &#038; Hers Health, Novo Nordisk, PayPal, Uber And BWX Technologies: Why These 5 Stocks Are On Investors&#8217; Radars Today &#8211; Hims &#038; Hers Health (NYSE:HIMS)"},"content":{"rendered":"<p class=\"block core-block\">Major U.S. indices traded higher Monday, with Dow Jones Futures edging up 0.09% to 48,893, the S&amp;P 500 advancing 0.12% to 6,860.50 and the Nasdaq climbing 0.18% to 24,808.25.<\/p>\n<p class=\"block core-block\">These are the top stocks that gained the attention of retail traders and investors through the day.<\/p>\n<p>Hims &amp; Hers Health Inc.\u00a0<a href=\"https:\/\/www.benzinga.com\/quote\/HIMS\" target=\"_blank\" class=\"ticker-link\" data-ticker=\"HIMS\" data-exchange=\"NYSE\" rel=\"nofollow noopener\">(NYSE:<\/a><a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/HIMS\" target=\"_blank\" rel=\"nofollow noopener\">HIMS<\/a>)<\/p>\n<p class=\"block core-block\">Hims &amp; Hers Health shares fell 0.77% to close at $15.51, with an intraday high of $15.80 and a low of $15.16. The stock\u2019s 52-week range is $15.16 to $70.43. In the after-hours trading, the stock fell 8.45% to $14.20.<\/p>\n<p class=\"block core-block\">The company guided first-quarter revenue of $600 million to $625 million, below estimates of $653.12 million, and projected full-year 2026 revenue of $2.7 billion to $2.9 billion, compared with expectations of $2.74 billion.<\/p>\n<p>Novo Nordisk A\/S\u00a0<a href=\"https:\/\/www.benzinga.com\/quote\/NVO\" target=\"_blank\" class=\"ticker-link\" data-ticker=\"NVO\" data-exchange=\"NYSE\" rel=\"nofollow noopener\">(NYSE:<\/a><a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/NVO\" target=\"_blank\" rel=\"nofollow noopener\">NVO<\/a>)<\/p>\n<p class=\"block core-block\">Novo Nordisk saw a significant drop of 16.43%, closing at $39.63. The stock hit an intraday high of $41.09 and a low of $39.34, marking a new 52-week low. <\/p>\n<p class=\"block core-block\">The setback was viewed by analysts as a worst-case outcome that weakened Novo Nordisk&#8217;s competitive position in the obesity market, with further data from REDEFINE 11 expected in 2027 and a higher-dose trial slated to begin in late 2026.<\/p>\n<p class=\"block core-block\">PayPal\u2019s stock rose 5.76%, ending the day at $44.05. The stock reached a high of $45.69 and a low of $40.52, with a 52-week range of $38.46 to $79.50. <\/p>\n<p class=\"block core-block\">The takeover interest emerged amid leadership upheaval, including a CEO change effective March 1, 2026, slowing Branded Checkout growth to 1% from 5%\u20136% in prior quarters, and a reduced fiscal 2026 outlook projecting a single-digit earnings decline to slight growth.<\/p>\n<p>Uber Technologies Inc.\u00a0<a href=\"https:\/\/www.benzinga.com\/quote\/UBER\" target=\"_blank\" class=\"ticker-link\" data-ticker=\"UBER\" data-exchange=\"NYSE\" rel=\"nofollow noopener\">(NYSE:<\/a><a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/UBER\" target=\"_blank\" rel=\"nofollow noopener\">UBER<\/a>)<\/p>\n<p class=\"block core-block\">Uber\u2019s shares declined by 4.25%, closing at $70.72. The stock\u2019s intraday high was $73.11, with a low of $70.15, and a 52-week range of $60.63 to $101.99. <\/p>\n<p class=\"block core-block\">Shares fell about 4.5% to $73.15, with investors also looking ahead to the May 6, 2026, earnings report, where revenue was estimated at $13.30 billion, up from $11.53 billion a year earlier, and earnings were projected at $0.71 per share, down from $0.83 year over year.<\/p>\n<p>BWX Technologies Inc.\u00a0<a href=\"https:\/\/www.benzinga.com\/quote\/BWXT\" target=\"_blank\" class=\"ticker-link\" data-ticker=\"BWXT\" data-exchange=\"NYSE\" rel=\"nofollow noopener\">(NYSE:<\/a><a class=\"ticker\" href=\"https:\/\/www.benzinga.com\/quote\/BWXT\" target=\"_blank\" rel=\"nofollow noopener\">BWXT<\/a>)<\/p>\n<p class=\"block core-block\">BWX Technologies experienced a 3.90% drop, closing at $198.38. The stock\u2019s intraday high and low were $206 and $197.62, respectively, with a 52-week range of $84.21 to $220.57. In extended trading, the stock shot up over 9% to $216.40.<\/p>\n<p class=\"block core-block\">BWX Technologies Inc. reported fourth-quarter EPS of $1.08, beating estimates of $0.89 by 21.35%, while revenue increased $139.57 million from a year earlier. In the prior quarter, the company had topped EPS expectations by $0.15.<\/p>\n<p class=\"block core-block\">For fiscal 2026, BWX Technologies guided earnings to a range of $4.55 to $4.70 per share.<\/p>\n<p class=\"block core-block\">Benzinga Edge Stock Rankings indicate <a href=\"https:\/\/www.benzinga.com\/quote\/HIMS\" target=\"_blank\" rel=\"nofollow noopener\">HIMS stock<\/a> has Growth in the 86th percentile and Value in the 12th percentile.<\/p>\n<p class=\"block core-block\">This story was generated using <a href=\"https:\/\/www.benzinga.com\/author\/benzinga-neuro\" target=\"_blank\" rel=\"nofollow noopener\">Benzinga Neuro<\/a> and edited by <a href=\"https:\/\/www.benzinga.com\/author\/shivdeep-dhaliwal\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Shivdeep Dhaliwal<\/a><\/p>\n<p class=\"block core-block\">Photo Courtesy: Vintage Tone on Shutterstock.com<\/p>\n","protected":false},"excerpt":{"rendered":"Major U.S. indices traded higher Monday, with Dow Jones Futures edging up 0.09% to 48,893, the S&amp;P 500&hellip;\n","protected":false},"author":2,"featured_media":22555,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[271],"tags":[3967,3968,2088,2084,272,352,15180,2095,2096,4888,15181,15182,15183,15184],"class_list":{"0":"post-22554","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-novo-nordisk","8":"tag-category-equities","9":"tag-category-markets","10":"tag-category-news","11":"tag-cms-wordpress","12":"tag-novo-nordisk","13":"tag-pageisbzpro-bz","14":"tag-symbol-bwxt","15":"tag-symbol-hims","16":"tag-symbol-nvo","17":"tag-symbol-pypl","18":"tag-symbol-uber","19":"tag-tag-5-trending-stocks","20":"tag-tag-top-trending-stocks-today","21":"tag-tag-trending-stocks-today"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/22554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=22554"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/22554\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/22555"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=22554"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=22554"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=22554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}